- Ashok Leyland‘s vehicle sales for March were reported at 22,866 units.
- This represents a year-on-year decrease of 4.4%, down from 23,926 units sold in the same month the previous year.
- Total sales, including both local and international, saw a decrease of 4% year-on-year.
- Local sales, which make up the majority of Ashok Leyland‘s business, were down 6.9% year-on-year, at 21,317 units.
- Investment recommendations for the company currently stand at 27 buys, 8 holds, and 9 sells.
- All comparisons to past results are based on values reported by the company in their original disclosures.
A look at Ashok Leyland Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to the Smartkarma Smart Scores, Ashok Leyland has a positive long-term outlook. The company received a score of 5 for both dividend and growth, indicating that it is performing well in these areas. Ashok Leyland is known for manufacturing medium and heavy duty commercial vehicles, such as buses and dump trucks, as well as industrial and marine engines. The company also sells its products in both domestic and international markets.
While Ashok Leyland received a score of 2 for both value and resilience, its momentum score was 3 out of 5. This suggests that the company has room for improvement in terms of its value and resilience, but is showing steady momentum in its overall performance. Overall, Ashok Leyland‘s Smart Scores indicate that it is a strong and growing company in the commercial vehicle industry, with a focus on international expansion and diversification into other areas such as industrial engines and spare parts.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
